Several factors have contributed to this resilience. Primarily, there’s the increasingly probable scenario of a soft landing in the U.S. economy.Additionally, a positive overall Q4…
Let’s take a deep dive into the company’s financials with our best-in-breed fundamental analysis tool, InvestingPro, to better understand what are the company’s risks and…
3 Under-the-Radar High-Growth Stocks Poised for Double-Digit Gains
However, this doesn’t necessarily imply there aren’t great high-growth opportunities out there waiting to be scooped up.While finding such companies amid the ocean of information…
2 Reasons Why February May Be a Difficult Month on Wall Street
Since 1945, the S&P 500 has suffered an average loss of around -0.3% in February.That compares to an average gain of roughly +0.8% for the…
Having risen 8.9% since the beginning of the year, the tech behemoth’s stock attained a new all-time closing high of $409.72 yesterday, as its market…
4 Under-the-Radar Gems Unearthed by ProPicks’ Cutting-Edge AI
Let me introduce you to the new InvestingPro tool that could make that dream a possibility – ProPicks. This innovative tool uncovers hidden gems in…
While the Santa Clara, California-based company has faced declines in the PC sales segment, its latest artificial intelligence chips, such as the Gaudi3, which is…
To understand how Netflix is positioned before the upcoming report, we’re using our latest tool: ProTips.Exclusive to InvestingPro subscribers, ProTips gives quick, straightforward info to…
With improved U.S. economic data and easing disinflation, the likelihood of March interest rate cuts has diminished. Consequently, the EUR/USD pair is gradually moving southward,…
Street Calls of the Week: An Apple a Day…
InvestingPro subscribers always get first dibs on market-moving rating changes.What happened? On Tuesday, Wells Fargo downgraded Boeing Co (NYSE:BA) to Equal-weight with a $225 price…
Franklin Templeton launches spot Bitcoin ETF
Johnson underscored the company’s commitment to blockchain innovation, which is not new to Franklin Templeton’s strategic initiatives. The firm has previously engaged in tokenization efforts…
Vertex (VRTX), CRSP’s Casgevy Gets FDA Nod for Thalassemia
Vertex Pharmaceuticals VRTX, along with CRISPR Therapeutics CRSP, announced that the FDA expanded the label of their one-shot gene therapy Casgevy to treat transfusion-dependent beta…





